egfr mutation analysis kit Search Results


egfr mutations analysis kit  (EntroGen Inc)
90
EntroGen Inc egfr mutations analysis kit
Patients' characteristics.
Egfr Mutations Analysis Kit, supplied by EntroGen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/egfr+mutation+analysis+kit/egfr+mutation+analysis+kit/pmc05453045-211-9-8
Average 90 stars, based on 1 article reviews
egfr mutations analysis kit - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
human egfr mutation analysis kit for real-time pcr  (EntroGen Inc)
90
EntroGen Inc human egfr mutation analysis kit for real-time pcr
Patients' characteristics.
Human Egfr Mutation Analysis Kit For Real Time Pcr, supplied by EntroGen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/egfr+mutation+analysis+kit/human+egfr+mutation+analysis+kit+for+real+time+pcr/pm28218040-26-22-24
Average 90 stars, based on 1 article reviews
human egfr mutation analysis kit for real-time pcr - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Patients' characteristics.

Journal: Oncology Letters

Article Title: Comparison of the effectiveness of erlotinib, gefitinib, and afatinib for treatment of non-small cell lung cancer in patients with common and rare EGFR gene mutations

doi: 10.3892/ol.2017.5980

Figure Lengend Snippet: Patients' characteristics.

Article Snippet: EGFR mutations were determined using RT-PCR and the EntroGen EGFR Mutations Analysis kit.

Techniques: Biomarker Discovery

Response to EGFR-TKI treatment according to demographic and clinical characteristics.

Journal: Oncology Letters

Article Title: Comparison of the effectiveness of erlotinib, gefitinib, and afatinib for treatment of non-small cell lung cancer in patients with common and rare EGFR gene mutations

doi: 10.3892/ol.2017.5980

Figure Lengend Snippet: Response to EGFR-TKI treatment according to demographic and clinical characteristics.

Article Snippet: EGFR mutations were determined using RT-PCR and the EntroGen EGFR Mutations Analysis kit.

Techniques: Biomarker Discovery

Progression-free survival (PFS) in NSCLC patients treated with EGFR-TKIs.

Journal: Oncology Letters

Article Title: Comparison of the effectiveness of erlotinib, gefitinib, and afatinib for treatment of non-small cell lung cancer in patients with common and rare EGFR gene mutations

doi: 10.3892/ol.2017.5980

Figure Lengend Snippet: Progression-free survival (PFS) in NSCLC patients treated with EGFR-TKIs.

Article Snippet: EGFR mutations were determined using RT-PCR and the EntroGen EGFR Mutations Analysis kit.

Techniques: Biomarker Discovery

Overall survival (OS) in NSCLC patients treated with EGFR-TKIs.

Journal: Oncology Letters

Article Title: Comparison of the effectiveness of erlotinib, gefitinib, and afatinib for treatment of non-small cell lung cancer in patients with common and rare EGFR gene mutations

doi: 10.3892/ol.2017.5980

Figure Lengend Snippet: Overall survival (OS) in NSCLC patients treated with EGFR-TKIs.

Article Snippet: EGFR mutations were determined using RT-PCR and the EntroGen EGFR Mutations Analysis kit.

Techniques: Biomarker Discovery